A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection
Study sponsor: Assembly Biosciences
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-12-02Actual
Enrollment · participants54Actual
Source updated2023-10-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.